ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2021 Congress

Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies » VWF and von Willebrand Factor Disorders - Clinical Conditions

Theme Navigation

  • ISTH 2021 Congress
    • Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies
      • VWF and von Willebrand Factor Disorders - Clinical Conditions

Abstract Number: PB0933

A Quantitative Evaluation of vWF Multimeric Structure in Patients with Different Types of vWD and aVWS

A. Poletaev1, E. Seregina1,2, N. Karamyan1, P. Zharkov1

Abstract Number: PB0952

Acquired von Willebrand Disease

M. Escobar1, K. Chong2, N. Montanez1

Abstract Number: PB0938

Acquired von Willebrand Disease: The Diagnosis and Management of an Underdiagnosed Coagulopathy

A. Ferretti1, E. Baldacci1, S. Lancellotti2, M. Basso2, F. Barone2, A. Pallotta3, G. Lapietra1, M. Sacco2, A. Chistolini1, E. De Candia2, C. Santoro1

Abstract Number: LPB0031

Activity and Cleavage of von Willebrand Disease Type 2B Variants

M. Brehm1, Y. Yildiz2, T. Obser1, A. Mojzisch1, S. Peine3, S. Schneppenheim4, U. Budde4, R. Schneppenheim5

Abstract Number: OC 13.3

Association of Genetic Alterations with Severity of Disease in Type III vWD Patients

M.A. Naveed1, S. Khaliq1, S. Mohsin1, A. Abid2, U. Saleem3, A. Ammar1

Abstract Number: PB0943

Atypical Presentation of VWD Leading to Discovery of Novel VWF Mutation

T. van de Berg1, A.M Todaro1, J. van Beers2, K. Wichapong1, F. Heubel-Moenen3, E. Castoldi1, Y. Henskens2, E. Beckers3

Abstract Number: OC 72.1

BT200 Increases von Willebrand Factor (VWF), FVIII and Platelet Counts in Patients with von Willebrand Disease (VWD) Type IIb

C. Ay1, I. Pabinger1, P. Quehenberger2, P. Jilma-Stohlawetz2, K. Kovacevic3, C. Schoergenhofer3, J.C. Gilbert4, S. Zhu4, B. Jilma3, U. Derhaschnig3

Abstract Number: PB0924

Burden of Illness in Patients with von Willebrand Disease: A Systematic Review

P. Du1, A. Bergamasco2, T. Arredondo-Bisono2, Y. Moride2,3,4, F. Truong Berthoz5, G. Özen6, S. Tzivelekis7

Abstract Number: PB0927

Characteristics and Treatment of Patients with von Willebrand Disease (VWD) in General Practice Settings in the United Kingdom

P. Du1, K. Wilcox Hagberg2, S. Tzivelekis3, F. Truong Berthoz4, G. Özen5, S. Jick2,6

Abstract Number: PB0923

Clinical, Economic, and Quality of Life Burden Associated with von Willebrand Disease (VWD) in Adults and Children: Systematic and Targeted Literature Reviews

G. Castaman1, N. Jansen2, S. Santos2, E. Berntorp3

Abstract Number: PB0935

Congenital Bleeding Disorders in Adolescent Females Evaluated for Menorrhagia and Iron Deficiency Anemia

A. Trillo1, R. Leeman1, J. Davis2, F.F. Corrales-Medina2

Abstract Number: PB0947

Correlation of VWF:Ab to VWF:Ag Ratio and Abnormal VWF Multimer Pattern

M. Stuart1, D. Chen1, N. Heikal1, R. Pruthi1

Abstract Number: PB0937

Diagnosis of von Willebrand Disease-intricacies and Challenges: An Experience from a Tertiary Care Centre in Southern India

R. Kar1, K. Balakrishnan1, A. Logaiyappan1, J. Jayachandan1, D. Basu1

Abstract Number: PB0926

Don’t Let Bleeding Go Unnoticed – A Global Initiative to Increase Awareness of von Willebrand Disease

F.F. Corrales-Medina1,2, E. Berntorp3

Abstract Number: PB0934

Efficacy of hFVIII/VWF Concentrate in Pediatric Patients with von Willebrand Disease (VWD): The French Experience

A. Harroche1, L. Rugeri2, R. D'Oiron3, A. Hassoun4, Y. Repesse5, B. Frotscher6, A. Fournel7, D. Bracquart8, C. Martin8, M. Trossaert9, S. Meunier2

Abstract Number: PB0945

Finding the Balance between Bleeding Risk and Thromboembolic Risk: A Case Report

B. Merchan Muñoz1, S. Herrero Martín1, M.I. Nuevo López1, M. Mora Argumánez1

Abstract Number: LPB0032

Genetic Characterization of von Willebrand Disease Type 2 in Milan Cohort Patients

O. Seidizadeh1, L. Baronciani1, M.T. Pagliari1, G. Cozzi1, P. Colpani1, S.M. Siboni1, E. Biguzzi1, F. Peyvandi1,2

Abstract Number: PB0936

High Plasma von Willebrand Factor Level is Associated with Increased Risk of upper Gastrointestinal Bleeding in Patients with Chronic Coronary Syndromes Receiving Long-term Antiplatelet Therapy

V. Korobkova1, A. Komarov1, O. Shakhmatova1, A. Dobrovolsky1, E. Novikova1, E. Guskova1, E. Titaeva1, E. Yarovaya2, A. Shuleshova1, E. Panchenko1

Abstract Number: PB0916

Increased Cleavage of VWF by ADAMTS13 Might Reduce High-molecular-weight VWF Multimers, Leading to Acquired von Willebrand Syndrome in Patients with Essential Thrombocythemia

M. Kubo1,2, H. Kashiwagi3, H. Yagi4, Y. Seki5, A. Hasegawa2, H. Tanaka2, I. Amano2, Y. Tomiyama6, M. Matsumoto1

Abstract Number: PB0948

Intermittent Prophylaxis for Heavy Menstrual Bleeding in Von Willebrand Disease

P. Laguna1, A. Laguna2, M. Matysiak1

  • 1
  • 2
  • 3
  • Next Page »

« View all themes from the ISTH 2021 Congress

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley